astrazeneca cspc - Search News

News

CSPC, AstraZeneca and AI

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions.

The Wall Street Journal on MSN · 3d

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

The deal with China’s CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.

BioSpace · 3d

AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

3hon MSN

Health Care Roundup: Market Talk

Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.

Fierce Biotech3d

AstraZeneca pens $5.3B pact to use CSPC's AI platform to develop oral drugs for chronic diseases

CSPC will use its artificial-intelligence-driven, dual-engine efficient drug discovery platform to analyze the binding ...

MedCity News3d

AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results